Hurley S F, Livingston P M, Thane N, Quang L
Cancer Epidemiology Centre, Anti-Cancer Council of Victoria, Australia.
J Epidemiol Community Health. 1994 Aug;48(4):391-9. doi: 10.1136/jech.48.4.391.
To estimate the cost per woman participating in a mammographic screening programme, and to describe methods for measuring costs.
Expenditure, resource usage, and throughput were monitored over a 12 month period. Unit costs for each phase of the screening process were estimated and linked with the probabilities of each screening outcome to obtain the cost per woman screened and the cost per breast cancer detected.
A pilot, population based Australian programme offering free two-view mammographic screening.
A total of 5986 women aged 50-69 years who lived in the target area, were listed on the electoral roll, had no previous breast cancer, and attended the programme.
Unit costs for recruitment, screening, and recall mammography were $17.54, $60.04, and $175.54, respectively. The costs of clinical assessment for women with subsequent clear, benign, malignant (palpable), and malignant (impalpable) diagnoses were $173.71, $527.29, $436.62, and $567.22, respectively. The cost per woman screened was $117.70, and the cost per breast cancer detected was $11,550.
The cost per woman screened is a key variable in assessment of the cost effectiveness of mammographic screening, and is likely to vary between health care settings. Its measurement is justified if decisions about health care services are to be based on cost effectiveness criteria.
估算参与乳腺钼靶筛查项目的每位女性的成本,并描述成本测量方法。
在12个月期间监测支出、资源使用和工作量。估算筛查过程各阶段的单位成本,并将其与每种筛查结果的概率相关联,以得出每位接受筛查女性的成本以及每例检测出的乳腺癌的成本。
一项基于澳大利亚人群的试点项目,提供免费的双视角乳腺钼靶筛查。
共有5986名年龄在50 - 69岁之间、居住在目标区域、登记在选民名单上、既往无乳腺癌且参加了该项目的女性。
招募、筛查和召回钼靶检查的单位成本分别为17.54美元、60.04美元和175.54美元。后续诊断为明确、良性、恶性(可触及)和恶性(不可触及)的女性的临床评估成本分别为173.71美元、527.29美元、436.62美元和567.22美元。每位接受筛查女性的成本为117.70美元,每例检测出的乳腺癌的成本为11550美元。
每位接受筛查女性的成本是评估乳腺钼靶筛查成本效益的关键变量,且可能因医疗保健环境而异。如果要根据成本效益标准做出关于医疗保健服务的决策,那么对其进行测量是合理的。